Bovie Medical (NYSE:BVX) said this week it inked a sales channel partnership agreement with Arteriocyte Medical Systems to sell Bovie's J-Plasma to its network of plastic surgeons. Through the deal, Arteriocyte will offer J-Plasma through its U.S. sales network, which Clearwater, Fla.-based Bovie said will significantly expand its use in office-based practices. "We are delighted to sign [...]The post Bovie inks J-Plasma distribution deal with Arteriocyte appeared first on MassDevice.